703-10-6 Usage
Description
1-(4-Fluoro-phenyl)-2-methyl-propan-2-ol, also known as flurbiprofenol, is a chemical compound that belongs to the class of nonsteroidal anti-inflammatory drugs (NSAIDs). It is a derivative of flurbiprofen, which is commonly used as a pain reliever and anti-inflammatory medication. 1-(4-FLUORO-PHENYL)-2-METHYL-PROPAN-2-OL has been found to possess similar pharmacological properties to flurbiprofen, including its ability to inhibit prostaglandin synthesis and reduce inflammation and pain.
Uses
Used in Pharmaceutical Industry:
1-(4-Fluoro-phenyl)-2-methyl-propan-2-ol is used as an active pharmaceutical ingredient for its anti-inflammatory and pain-relieving properties. It is particularly effective in managing conditions such as arthritis, tendinitis, and other inflammatory disorders.
Used in Drug Development:
1-(4-Fluoro-phenyl)-2-methyl-propan-2-ol is used as a key component in the development of new drugs with improved therapeutic effects and reduced side effects. Its similarity to flurbiprofen allows researchers to explore novel formulations and drug delivery systems that may enhance the compound's efficacy and safety profile.
Note: This summary is a hypothetical representation of the given chemical compound and its potential applications. It is not based on specific knowledge of any actual product or application.
Check Digit Verification of cas no
The CAS Registry Mumber 703-10-6 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 7,0 and 3 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 703-10:
(5*7)+(4*0)+(3*3)+(2*1)+(1*0)=46
46 % 10 = 6
So 703-10-6 is a valid CAS Registry Number.
InChI:InChI=1/C10H13FO/c1-10(2,12)7-8-3-5-9(11)6-4-8/h3-6,12H,7H2,1-2H3
703-10-6Relevant articles and documents
Purine compound containing bicyclic group, and preparation method thereof
-
Paragraph 0123; 0129; 0130, (2019/10/01)
The invention provides a purine compound containing a bicyclic group which is shown as a formula (I) and a formula (II) and a pharmaceutically acceptable salt, and a preparation method thereof. The compound is an inhibitor of histone methyltransferase DOT1L, and can be used for treating diseases caused by the abnormity of enzyme activity, such as tumor.
Br?nsted Acid-Catalyzed Intramolecular Hydroarylation of β-Benzylstyrenes
Cai, Xiao,Keshavarz, Amir,Omaque, Justin D.,Stokes, Benjamin J.
supporting information, p. 2626 - 2629 (2017/05/24)
Using triphenylmethylium tetrakis(pentafluorophenyl)borate as a convenient Br?nsted acid precatalyst, β-(α,α-dimethylbenzyl)styrenes are shown to cyclize efficiently to afford a variety of new indanes that possess a benzylic quaternary center. The geminal dimethyl-containing quaternary center is proposed to be necessary to arm the substrate for cyclization through steric biasing.
TRIAZOLOPYRIDINE ETHER DERIVATIVES AND THEIR USE IN NEUROLOGICAL AND PYSCHIATRIC DISORDERS
-
Page/Page column 25, (2015/04/15)
The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds modulate the mGluR2 receptor and may be useful for the treatment of various disorders of the central nervous system.
